DRAQ7™ enables
real-time toxicity and viability assays
- DRAQ7™
is non-toxic to cells over several days exposure
- DRAQ7™
does not alter dose-response profiles for anti-cancer
agents
- DRAQ7™
gives a sensitive real-time readout for cell death induced
by hypoxia, starvation, drug treatment ..
- DRAQ7™
has full spectral compatibility with Hoechst 33342, FITC/GFP and the orange/red MMP probes
REFERENCE:
Akagi,
J. et al. Real-time cell viability assays using a new anthracycline derivative
DRAQ7.
Cytomery
Part A. Early View – published online November 16, 2012
DOI: 10.1002/cyto.a.22228
